Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-29610197

ABSTRACT

The antifungal drug 5-flucytosine (5FC), a derivative of the nucleobase cytosine, is licensed for the treatment of fungal diseases; however, it is rarely used as a monotherapeutic to treat Aspergillus infection. Despite being potent against other fungal pathogens, 5FC has limited activity against Aspergillus fumigatus when standard in vitro assays are used to determine susceptibility. However, in modified in vitro assays where the pH is set to pH 5, the activity of 5FC increases significantly. Here we provide evidence that fcyB, a gene that encodes a purine-cytosine permease orthologous to known 5FC importers, is downregulated at pH 7 and is the primary factor responsible for the low efficacy of 5FC at pH 7. We also uncover two transcriptional regulators that are responsible for the repression of fcyB and, consequently, mediators of 5FC resistance, the CCAAT binding complex (CBC) and the pH regulatory protein PacC. We propose that the activity of 5FC might be enhanced by the perturbation of factors that repress fcyB expression, such as PacC or other components of the pH-sensing machinery.


Subject(s)
Antifungal Agents/pharmacology , Aspergillus fumigatus/drug effects , Flucytosine/pharmacology , Fungal Proteins/metabolism , Transcription Factors/metabolism , Aspergillus fumigatus/metabolism , Drug Resistance, Fungal/genetics , Fungal Proteins/genetics , Hydrogen-Ion Concentration , Microbial Sensitivity Tests , Transcription Factors/genetics
3.
PLoS Pathog ; 12(7): e1005775, 2016 07.
Article in English | MEDLINE | ID: mdl-27438727

ABSTRACT

Azole drugs selectively target fungal sterol biosynthesis and are critical to our antifungal therapeutic arsenal. However, resistance to this class of drugs, particularly in the major human mould pathogen Aspergillus fumigatus, is emerging and reaching levels that have prompted some to suggest that there is a realistic probability that they will be lost for clinical use. The dominating class of pan-azole resistant isolates is characterized by the presence of a tandem repeat of at least 34 bases (TR34) within the promoter of cyp51A, the gene encoding the azole drug target sterol C14-demethylase. Here we demonstrate that the repeat sequence in TR34 is bound by both the sterol regulatory element binding protein (SREBP) SrbA, and the CCAAT binding complex (CBC). We show that the CBC acts complementary to SrbA as a negative regulator of ergosterol biosynthesis and show that lack of CBC activity results in increased sterol levels via transcriptional derepression of multiple ergosterol biosynthetic genes including those coding for HMG-CoA-synthase, HMG-CoA-reductase and sterol C14-demethylase. In agreement with these findings, inactivation of the CBC increased tolerance to different classes of drugs targeting ergosterol biosynthesis including the azoles, allylamines (terbinafine) and statins (simvastatin). We reveal that a clinically relevant mutation in HapE (P88L) significantly impairs the binding affinity of the CBC to its target site. We identify that the mechanism underpinning TR34 driven overexpression of cyp51A results from duplication of SrbA but not CBC binding sites and show that deletion of the 34 mer results in lack of cyp51A expression and increased azole susceptibility similar to a cyp51A null mutant. Finally we show that strains lacking a functional CBC are severely attenuated for pathogenicity in a pulmonary and systemic model of aspergillosis.


Subject(s)
Aspergillosis/metabolism , Aspergillus fumigatus/metabolism , CCAAT-Binding Factor/metabolism , Drug Resistance, Fungal/physiology , Sterol Regulatory Element Binding Proteins/metabolism , Animals , Antifungal Agents , Azoles , Chromatin Immunoprecipitation , Cytochrome P-450 Enzyme System/metabolism , Disease Models, Animal , Fungal Proteins/metabolism , Male , Mice , Microbial Sensitivity Tests , Microscopy, Fluorescence , Polymerase Chain Reaction , Sterols/biosynthesis
4.
Nat Commun ; 5: 3742, 2014 Apr 29.
Article in English | MEDLINE | ID: mdl-24776982

ABSTRACT

Variation of mutation rate at a particular site in a particular genotype, in other words mutation rate plasticity (MRP), can be caused by stress or ageing. However, mutation rate control by other factors is less well characterized. Here we show that in wild-type Escherichia coli (K-12 and B strains), the mutation rate to rifampicin resistance is plastic and inversely related to population density: lowering density can increase mutation rates at least threefold. This MRP is genetically switchable, dependent on the quorum-sensing gene luxS--specifically its role in the activated methyl cycle--and is socially mediated via cell-cell interactions. Although we identify an inverse association of mutation rate with fitness under some circumstances, we find no functional link with stress-induced mutagenesis. Our experimental manipulation of mutation rates via the social environment raises the possibility that such manipulation occurs in nature and could be exploited medically.


Subject(s)
Drug Resistance, Bacterial/genetics , Escherichia coli/physiology , Genetic Variation , Microbial Interactions/physiology , Mutation Rate , Rifampin , Analysis of Variance , Bacterial Proteins/metabolism , Carbon-Sulfur Lyases/metabolism , DNA Primers/genetics , Escherichia coli/genetics , Genetic Fitness/genetics , Population Density , Real-Time Polymerase Chain Reaction
5.
Mol Biosyst ; 10(1): 93-102, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24157722

ABSTRACT

Multiple drug resistance (MDR) in yeast is effected by two major superfamilies of membrane transporters: the major facilitator superfamily (MFS) and the ATP-binding cassette (ABC) superfamily. In the present work, we investigated the cellular responses to disruptions in both MFS (by deleting the transporter gene, QDR3) and ABC (by deleting the gene for the Pdr3 transcription factor) transporter systems by growing diploid homozygous deletion yeast strains in glucose- or ammonium-limited continuous cultures. The transcriptome and the metabolome profiles of these strains, as well as the flux distributions in the optimal solution space, reveal novel insights into the underlying mechanisms of action of QDR3 and PDR3. Our results show how cells rearrange their metabolism to cope with the problems that arise from the loss of these drug-resistance genes, which likely evolved to combat chemical attack from bacterial or fungal competitors. This is achieved through the accumulation of intracellular glucose, glycerol, and inorganic phosphate, as well as by repurposing genes that are known to function in other parts of metabolism in order to minimise the effects of toxic compounds.


Subject(s)
ATP-Binding Cassette Transporters/genetics , DNA-Binding Proteins/genetics , Drug Resistance, Multiple/genetics , Membrane Transport Proteins/genetics , Saccharomyces cerevisiae Proteins/genetics , Transcription Factors/genetics , ATP-Binding Cassette Transporters/metabolism , DNA-Binding Proteins/metabolism , Fungal Proteins/biosynthesis , Glucose/metabolism , Glycerol/metabolism , Membrane Transport Proteins/metabolism , Metabolome/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/metabolism , Transcription Factors/metabolism , Transcriptome/genetics
6.
Microb Cell ; 1(7): 250-252, 2014 Jun 25.
Article in English | MEDLINE | ID: mdl-28357250

ABSTRACT

We do not need to rehearse the grim story of the global rise of antibiotic resistant microbes. But what if it were possible to control the rate with which antibiotic resistance evolves by de novo mutation? It seems that some bacteria may already do exactly that: they modify the rate at which they mutate to antibiotic resistance dependent on their biological environment. In our recent study [Krasovec, et al. Nat. Commun. (2014), 5, 3742] we find that this modification depends on the density of the bacterial population and cell-cell interactions (rather than, for instance, the level of stress). Specifically, the wild-type strains of Escherichia coli we used will, in minimal glucose media, modify their rate of mutation to rifampicin resistance according to the density of wild-type cells. Intriguingly, the higher the density, the lower the mutation rate (Figure 1). Why this novel density-dependent 'mutation rate plasticity' (DD-MRP) occurs is a question at several levels. Answers are currently fragmentary, but involve the quorum-sensing gene luxS and its role in the activated methyl cycle.

7.
Open Biol ; 3(5): 120137, 2013 May 22.
Article in English | MEDLINE | ID: mdl-23697803

ABSTRACT

The proteasome has been implicated in gene transcription through a variety of mechanisms. How the proteasome regulates genome-wide transcription in relation to nutrient signalling pathways is largely unknown. Using chemical inhibitors to compromise the functions of the proteasome and/or TORC1, we reveal that the proteasome and TORC1 synergistically promote the expression of de novo purine and amino acid biosynthetic genes, and restrict the transcription of those associated with proteolysis, starvation and stress responses. Genetic analysis demonstrates that TORC1 negatively regulates both the Yak1 and Rim15 kinases to modulate starvation-specific gene expression mediated by the Msn2/4 and Gis1 transcription factors. Compromising proteasome function induces starvation-specific gene transcription in exponential-phase cells and abrogates the strict control of such expression by Yak1 and Rim15 in rapamycin-treated cells, confirming that the proteasome functions to ensure stringent control of the starvation response by the TOR pathway. Synergy between the two pathways is also exhibited on cell growth control. Rpn4-dependent upregulation of proteasomal genes and a catalytically competent 20S proteasome are essential for yeast cells to respond to reduced TORC1 activity. These data suggest that the proteasome and the TOR signalling pathway synergistically regulate a significant portion of the genome to coordinate cell growth and starvation response.


Subject(s)
Cell Cycle/physiology , Gene Expression Regulation, Fungal , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Signal Transduction/genetics , TOR Serine-Threonine Kinases/metabolism , Transcription Factors/metabolism , Antifungal Agents/pharmacology , Cell Cycle/genetics , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Histone Demethylases/genetics , Histone Demethylases/metabolism , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Proteasome Endopeptidase Complex/genetics , Proteasome Endopeptidase Complex/metabolism , Protein Kinases/metabolism , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Signal Transduction/drug effects , Signal Transduction/physiology , Sirolimus/pharmacology , Stress, Physiological , Transcription Factors/genetics , Transcription, Genetic , Transcriptome
8.
BMC Syst Biol ; 6: 4, 2012 Jan 13.
Article in English | MEDLINE | ID: mdl-22244311

ABSTRACT

BACKGROUND: Control of growth rate is mediated by tight regulation mechanisms in all free-living organisms since long-term survival depends on adaptation to diverse environmental conditions. The yeast, Saccharomyces cerevisiae, when growing under nutrient-limited conditions, controls its growth rate via both nutrient-specific and nutrient-independent gene sets. At slow growth rates, at least, it has been found that the expression of the genes that exert significant control over growth rate (high flux control or HFC genes) is not necessarily regulated by growth rate itself. It has not been determined whether the set of HFC genes is the same at all growth rates or whether it is the same in conditions of nutrient limitation or excess. RESULTS: HFC genes were identified in competition experiments in which a population of hemizygous diploid yeast deletants were grown at, or close to, the maximum specific growth rate in either nutrient-limiting or nutrient-sufficient conditions. A hemizygous mutant is one in which one of any pair of homologous genes is deleted in a diploid, These HFC genes divided into two classes: a haploinsufficient (HI) set, where the hemizygous mutants grow slower than the wild type, and a haploproficient (HP) set, which comprises hemizygotes that grow faster than the wild type. The HI set was found to be enriched for genes involved in the processes of gene expression, while the HP set was enriched for genes concerned with the cell cycle and genome integrity. CONCLUSION: A subset of growth-regulated genes have HFC characteristics when grown in conditions where there are few, or no, external constraints on the rate of growth that cells may attain. This subset is enriched for genes that participate in the processes of gene expression, itself (i.e. transcription and translation). The fact that haploproficiency is exhibited by mutants grown at the previously determined maximum rate implies that the control of growth rate in this simple eukaryote represents a trade-off between the selective advantages of rapid growth and the need to maintain the integrity of the genome.


Subject(s)
Gene Expression Regulation, Fungal/physiology , Genes, Fungal/physiology , Genes, cdc/physiology , Saccharomyces cerevisiae/growth & development , Systems Biology/methods , Genes, Fungal/genetics , Genes, cdc/genetics , Genomic Instability/genetics , Haploinsufficiency/genetics , Models, Biological , Nutritional Physiological Phenomena/physiology
9.
BMC Syst Biol ; 5: 148, 2011 Sep 25.
Article in English | MEDLINE | ID: mdl-21943358

ABSTRACT

BACKGROUND: A microorganism is able to adapt to changes in its physicochemical or nutritional environment and this is crucial for its survival. The yeast, Saccharomyces cerevisiae, has developed mechanisms to respond to such environmental changes in a rapid and effective manner; such responses may demand a widespread re-programming of gene activity. The dynamics of the re-organization of the cellular activities of S. cerevisiae in response to the sudden and transient removal of either carbon or nitrogen limitation has been studied by following both the short- and long-term changes in yeast's transcriptomic profiles. RESULTS: The study, which spans timescales from seconds to hours, has revealed the hierarchy of metabolic and genetic regulatory switches that allow yeast to adapt to, and recover from, a pulse of a previously limiting nutrient. At the transcriptome level, a glucose impulse evoked significant changes in the expression of genes concerned with glycolysis, carboxylic acid metabolism, oxidative phosphorylation, and nucleic acid and sulphur metabolism. In ammonium-limited cultures, an ammonium impulse resulted in the significant changes in the expression of genes involved in nitrogen metabolism and ion transport. Although both perturbations evoked significant changes in the expression of genes involved in the machinery and process of protein synthesis, the transcriptomic response was delayed and less complex in the case of an ammonium impulse. Analysis of the regulatory events by two different system-level, network-based approaches provided further information about dynamic organization of yeast cells as a response to a nutritional change. CONCLUSIONS: The study provided important information on the temporal organization of transcriptomic organization and underlying regulatory events as a response to both carbon and nitrogen impulse. It has also revealed the importance of a long-term dynamic analysis of the response to the relaxation of a nutritional limitation to understand the molecular basis of the cells' dynamic behaviour.


Subject(s)
Adaptation, Physiological , Gene Expression Regulation, Fungal , Glucose/pharmacology , Quaternary Ammonium Compounds/pharmacology , Saccharomyces cerevisiae/genetics , Gene Expression Regulation, Fungal/drug effects , Gene Regulatory Networks , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/physiology , Time Factors , Transcriptome
10.
Methods Mol Biol ; 759: 73-86, 2011.
Article in English | MEDLINE | ID: mdl-21863482

ABSTRACT

In this protocol, we describe a pipeline for transcript analysis in yeast via the quantification of mRNA expression levels. In the first section, we consider the well-established, proprietary Affymetrix GeneChip® approach to generating transcriptomics data. In the next section, we concentrate on providing a detailed protocol for the validation of these data using quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). The protocol provides suggested examples of hardware, software, and consumables/reagents required to perform these experiments. There are of course many other options available using alternative approaches (or indeed suppliers), but this protocol is intended to provide an approach that is flexible, inexpensive, sensitive, and easy to use.


Subject(s)
Gene Expression Profiling/methods , Saccharomyces cerevisiae/genetics , DNA Primers/genetics , DNA, Fungal/genetics , DNA, Fungal/metabolism , Fluorescent Dyes/metabolism , Nucleic Acid Hybridization , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
11.
Mol Biosyst ; 7(1): 139-49, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20963216

ABSTRACT

Saccharomyces cerevisiae can survive extreme desiccation, but the molecular mechanisms are poorly understood. To define genes involved in desiccation tolerance, two complementary genome-wide approaches, phenomics and transcriptomics, have been used, together with a targeted analysis of gene deletion mutants tested individually for their ability to survive drying. Genome-wide phenotypic analyses carried out on a pooled library of single-gene deletion mutants subjected to three cycles of desiccation and re-growth to post-diauxic phase identified about 650 genes that contributed to strain survival in the drying process. Air-drying desiccation-tolerant post-diauxic phase cells significantly altered transcription in 12% of the yeast genome, activating expression of over 450 genes and down-regulating 330. Autophagy processes were significantly over-represented in both the phenomics study and the genes up-regulated on drying, indicating the importance of the clearance of protein aggregates/damaged organelles and the recycling of nutrients for the survival of desiccation in yeast. Functional carbon source sensing networks governed by the PKA, Tor and Snf1 protein kinase complexes were important for the survival of desiccation, as indicated by phenomics, transcriptomics, and individual analyses of mutant strains. Changes in nitrogen metabolism were evident during the drying process and parts of the environmental stress response were activated, repressing ribosome production and inducing genes for coping with oxidative and osmotic stress.


Subject(s)
Autophagy/physiology , Desiccation , Gene Expression Profiling/methods , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/physiology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/physiology , Autophagy/genetics , Gene Expression Regulation, Fungal/genetics , Gene Expression Regulation, Fungal/physiology , Oligonucleotide Array Sequence Analysis
12.
Genome Biol Evol ; 2: 591-601, 2010.
Article in English | MEDLINE | ID: mdl-20660110

ABSTRACT

Population-level differences in the number of copies of genes resulting from gene duplication and loss have recently been recognized as an important source of variation in eukaryotes. However, except for a small number of cases, the phenotypic effects of this variation are unknown. Data from the Saccharomyces Genome Resequencing Project permit the study of duplication in genome sequences from a set of individuals within the same population. These sequences can be correlated with available information on the environments from which these yeast strains were isolated. We find that yeast show an abundance of duplicate genes that are lineage specific, leading to a large degree of variation in gene content between individual strains. There is a detectable bias for specific functions, indicating that selection is acting to preferentially retain certain duplicates. Most strikingly, we find that sets of over- and underrepresented duplicates correlate with the environment from which they were isolated. Together, these observations indicate that gene duplication can give rise to substantial phenotypic differences within populations that in turn can offer a shortcut to evolutionary adaptation.


Subject(s)
Gene Duplication , Genes, Fungal , Saccharomyces cerevisiae/genetics , Saccharomyces/genetics , Adaptation, Biological/genetics , Chromosomes, Fungal/genetics , Environment , Evolution, Molecular , Genes, Duplicate , Genome, Fungal , Multigene Family , Phylogeny
13.
J Biotechnol ; 147(2): 136-43, 2010 May 17.
Article in English | MEDLINE | ID: mdl-20356564

ABSTRACT

Strains of Saccharomyces cerevisiae capable of lysis upon conditional down-regulation of cell-wall biogenesis genes (SRB1 and PKC1) have been reported. Here, we show that they lyse and release recombinant protein not only under laboratory conditions, but (more importantly) under conditions found in the human stomach and duodenum. These findings provide proof that, in principle, such conditional lysis strains could be used as an integral part of a system for the oral delivery of therapeutic proteins. However, the current mechanism of conditional lysis is based on the use of the MET3 promoter which requires addition of methionine and cysteine for down-regulation of SRB1 and PKC1. This requirement makes it difficult to apply in vivo. We reasoned that promoters, suitable for in vivo down-regulation of lysis-inducing genes, could be identified amongst yeast genes whose transcript abundance is reduced under conditions found in the human gut. A microarray experiment identified a number of candidate genes with significantly reduced transcript levels under simulated human gut conditions. The greatest effects were seen with ANB1, TIR1, and MF(ALPHA)2), and we propose that their promoters have the potential to be used in vivo to achieve yeast lysis in the gut.


Subject(s)
Cell Wall/chemistry , Duodenum/chemistry , Pharmaceutical Vehicles/chemistry , Saccharomyces cerevisiae/chemistry , Stomach/chemistry , Cell Proliferation , Cell Wall/genetics , Cell Wall/metabolism , Cysteine/metabolism , Duodenum/metabolism , Gastric Mucosa/metabolism , Gene Expression Profiling , Genes, Fungal , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Methionine/metabolism , Mutation , Nucleotidyltransferases/genetics , Nucleotidyltransferases/metabolism , Oligonucleotide Array Sequence Analysis/methods , Promoter Regions, Genetic , Protein Kinase C/genetics , Protein Kinase C/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism
14.
Nat Genet ; 40(1): 113-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18157128

ABSTRACT

Using competition experiments in continuous cultures grown in different nutrient environments (glucose limited, ammonium limited, phosphate limited and white grape juice), we identified genes that show haploinsufficiency phenotypes (reduced growth rate when hemizygous) or haploproficiency phenotypes (increased growth rate when hemizygous). Haploproficient genes (815, 1,194, 733 and 654 in glucose-limited, ammonium-limited, phosphate-limited and white grape juice environments, respectively) frequently show that phenotype in a specific environmental context. For instance, genes encoding components of the ubiquitination pathway or the proteasome show haploproficiency in nitrogen-limited conditions where protein conservation may be beneficial. Haploinsufficiency is more likely to be observed in all environments, as is the case with genes determining polar growth of the cell. Haploproficient genes seem randomly distributed in the genome, whereas haploinsufficient genes (685, 765, 1,277 and 217 in glucose-limited, ammonium-limited, phosphate-limited and white grape juice environments, respectively) are over-represented on chromosome III. This chromosome determines a yeast's mating type, and the concentration of haploinsufficient genes there may be a mechanism to prevent its loss.


Subject(s)
Genes, Fungal , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/genetics , Culture Media , Energy Metabolism , Gene Expression , Phenotype
15.
Antimicrob Agents Chemother ; 51(11): 3948-59, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17846143

ABSTRACT

Dermaseptin S3(1-16) [DsS3(1-16)] and magainin 2 (Mag 2) are two unrelated, amphibian-derived cationic peptides that adopt an alpha-helical structure within microbial membranes and have been proposed to kill target organisms via membrane disruption. Using a combination of global deletion mutant library phenotypic screening, expression profiling, and physical techniques, we have carried out a comprehensive in vitro analysis of the inhibitory action of these two peptides on the model fungus Saccharomyces cerevisiae. Gene ontology profiling (of biological processes) was used to identify both common and unique effects of each peptide. Resistance to both peptides was conferred by genes involved in telomere maintenance, chromosome organization, and double-strand break repair, implicating a common inhibitory action of DNA damage. Crucially, each peptide also required unique genes for maintaining resistance; for example, DsS3(1-16) required genes involved in protein targeting to the vacuole, and Mag 2 required genes involved in DNA-dependent DNA replication and DNA repair. Thus, DsS3(1-16) and Mag 2 have both common and unique antifungal actions that are not simply due to membrane disruption. Physical techniques revealed that both peptides interacted with DNA in vitro but in subtly different ways, and this observation was supported by the functional genomics experiments that provided evidence that both peptides also interfered with DNA integrity differently in vivo. This implies that both peptides are able to pass through the cytoplasmic membrane of yeast cells and damage DNA, an inhibitory action that has not been previously attributed to either of these peptides.


Subject(s)
Amphibian Proteins/pharmacology , Amphibians/metabolism , Antifungal Agents/pharmacology , Antimicrobial Cationic Peptides/pharmacology , Magainins/pharmacology , Saccharomyces cerevisiae/drug effects , Amphibian Proteins/chemistry , Animals , Antifungal Agents/chemistry , Antimicrobial Cationic Peptides/chemistry , DNA Repair/drug effects , DNA Replication/drug effects , DNA, Fungal/metabolism , Gene Expression Regulation, Fungal/drug effects , Genome, Fungal/genetics , Magainins/chemistry , Phenotype , Protein Structure, Secondary , Saccharomyces cerevisiae/genetics
16.
J Biol ; 6(2): 4, 2007.
Article in English | MEDLINE | ID: mdl-17439666

ABSTRACT

BACKGROUND: Cell growth underlies many key cellular and developmental processes, yet a limited number of studies have been carried out on cell-growth regulation. Comprehensive studies at the transcriptional, proteomic and metabolic levels under defined controlled conditions are currently lacking. RESULTS: Metabolic control analysis is being exploited in a systems biology study of the eukaryotic cell. Using chemostat culture, we have measured the impact of changes in flux (growth rate) on the transcriptome, proteome, endometabolome and exometabolome of the yeast Saccharomyces cerevisiae. Each functional genomic level shows clear growth-rate-associated trends and discriminates between carbon-sufficient and carbon-limited conditions. Genes consistently and significantly upregulated with increasing growth rate are frequently essential and encode evolutionarily conserved proteins of known function that participate in many protein-protein interactions. In contrast, more unknown, and fewer essential, genes are downregulated with increasing growth rate; their protein products rarely interact with one another. A large proportion of yeast genes under positive growth-rate control share orthologs with other eukaryotes, including humans. Significantly, transcription of genes encoding components of the TOR complex (a major controller of eukaryotic cell growth) is not subject to growth-rate regulation. Moreover, integrative studies reveal the extent and importance of post-transcriptional control, patterns of control of metabolic fluxes at the level of enzyme synthesis, and the relevance of specific enzymatic reactions in the control of metabolic fluxes during cell growth. CONCLUSION: This work constitutes a first comprehensive systems biology study on growth-rate control in the eukaryotic cell. The results have direct implications for advanced studies on cell growth, in vivo regulation of metabolic fluxes for comprehensive metabolic engineering, and for the design of genome-scale systems biology models of the eukaryotic cell.


Subject(s)
Eukaryotic Cells/physiology , Gene Expression Regulation, Fungal , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/physiology , Systems Biology/methods , Transcription, Genetic , Carbon/metabolism , Cell Culture Techniques , Gene Expression Profiling , Humans , Protein Kinases/genetics , Protein Kinases/metabolism , Signal Transduction , TOR Serine-Threonine Kinases
SELECTION OF CITATIONS
SEARCH DETAIL